Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of Jan-05-2024

  1. Eli Lilly and Company

    World Rank (Jan-05-2024)
    10
    Market Cap (Jan-05-2024)
    586.387 Billion USD
    World Rank (Jul-30-2023)
    16
    Market Cap (Jul-30-2023)
    435.220 Billion USD
    World Rank (Dec-25-2022)
    19
    Market Cap (Dec-25-2022)
    349.570 Billion USD
    World Rank (Jan-07-2022)
    39
    Market Cap (Jan-07-2022)
    248.24 Billion USD
    Annual Revenue in USD
    34,124 Million USD
    Annual Operating Income in USD
    10,787 Million USD
    Annual Net Income in USD
    5,240 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Eli Lilly is a healthcare and pharmaceutical company and is USA based MNC company. Key business areas are Oncology, Bio-Medicines, Diabetes and also Animals Health. Headquarters is in USA.

    As of Jan-05-2024, Eli Lilly market cap was 586 Billion USD and it is World Top 10th rank company by market cap.

    Facts About Eli Lilly as on 2022:

    Facts About Company

    As on 2022, Eli Lilly has 39,000 employees.

    Eli Lilly annual revenue generated for period ending Dec-2022 was 28,541 million USD.

    Eli Lilly annual net income generated for period ending Dec-2022 was 6,244 million USD.

    Eli Lilly annual revenue generated for period ending Dec-2021 was 28,318 million USD.

    Eli Lilly annual net income generated for period ending Dec-2021 was 5,581 million USD.

  2. Johnson & Johnson

    World Rank (Jan-05-2024)
    21
    Market Cap (Jan-05-2024)
    387.499 Billion USD
    World Rank (Jul-30-2023)
    15
    Market Cap (Jul-30-2023)
    453.430 Billion USD
    World Rank (Dec-25-2022)
    8
    Market Cap (Dec-25-2022)
    464.020 Billion USD
    World Rank (Jan-07-2022)
    14
    Market Cap (Jan-07-2022)
    457.94 Billion USD
    Annual Revenue in USD
    85,159 Million USD
    Annual Operating Income in USD
    22,009 Million USD
    Annual Net Income in USD
    35,153 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    Company Profile

    Johnson & Johnson manufactures Consumer Goods, Medical Devices and Equipment and Pharmaceutical Products. As on 2023, Johnson & Johnson has 155,800 employees across 60 countries. Headquarters is in USA.

    As on December-2021, The Company’s subsidiaries operate 85 manufacturing facilities occupying approximately 15.0 million square feet of floor space for managing consumer goods, medical devices and pharmaceutical business segments.

    Facts About Company
    • Johnson & Johnson annual revenue generated for period ending Dec-2023 was 85.15 Billion USD and annual net income was 35.15 Billion USD
    • Johnson & Johnson annual revenue generated for period ending Dec-2022 was 94.94 Billion USD and annual net income was 17.94 Billion USD.
    • Johnson & Johnson annual revenue generated for period ending Dec-2021 was 93.77 Billion USD and annual net income was 20.87 Billion USD.

    Johnson & Johnson annual sales by segment wise for period ending in Dec-2022:

  3. Merck & Co

    World Rank (Jan-05-2024)
    28
    Market Cap (Jan-05-2024)
    296.506 Billion USD
    World Rank (Jul-30-2023)
    32
    Market Cap (Jul-30-2023)
    269.830 Billion USD
    World Rank (Dec-25-2022)
    30
    Market Cap (Dec-25-2022)
    283.610 Billion USD
    World Rank (Jan-07-2022)
    59
    Market Cap (Jan-07-2022)
    202.83 Billion USD
    Annual Revenue in USD
    60,115 Million USD
    Annual Operating Income in USD
    2,954 Million USD
    Annual Net Income in USD
    365 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    Company Profile

    Merck & Co is USA based healthcare and pharmaceutical multi-national company. Merck Company manufacture and sells innovative medicines, vaccines, and animal health products. Headquarters is in USA.

    Merck & Co focus on scientific innovation to deliver medicines and vaccines.

    Facts About Company

    As on 2022, Merck & Co has 69,000 employees.

    For year ending Dec-2022, Merck & Co annual revenue was 59.28 billion USD and annual net income was 14.51 billion USD.

    For year ending Dec-2021, Merck & Co annual revenue was 48.70 million USD and annual net income was 13.04 million USD.

    Total Assets as on Dec-2022 was 109,160 Million USD.

  4. Abbvie

    World Rank (Jan-05-2024)
    32
    Market Cap (Jan-05-2024)
    285.064 Billion USD
    World Rank (Jul-30-2023)
    33
    Market Cap (Jul-30-2023)
    266.140 Billion USD
    World Rank (Dec-25-2022)
    29
    Market Cap (Dec-25-2022)
    288.440 Billion USD
    World Rank (Jan-07-2022)
    46
    Market Cap (Jan-07-2022)
    238.45 Billion USD
    Annual Revenue in USD
    54,318 Million USD
    Annual Operating Income in USD
    13,535 Million USD
    Annual Net Income in USD
    4,820 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Abbvie is USA based healthcare and pharmaceutical multi-national company. AbbVie is highly focus research-driven bio-pharmaceutical company. Headquarters is in USA.

    Facts About Company

    As on 2023, Abbvie has 50,000 employees.

    Abbvie annual revenue generated for period ending Dec-2022 was 58,054 million USD.

    Abbvie annual net income generated for period ending Dec-2022 was 11,782 million USD.

    Abbvie annual revenue generated for period ending Dec-2021 was 56,197 million USD.

    Abbvie annual net income generated for period ending Dec-2021 was 11,542 million USD.

    Total Assets as on Dec-2022 was 138,805 Million USD.

  5. Novartis AG

    World Rank (Jan-05-2024)
    45
    Market Cap (Jan-05-2024)
    216.513 Billion USD
    World Rank (Jul-30-2023)
    45
    Market Cap (Jul-30-2023)
    220.820 Billion USD
    World Rank (Dec-25-2022)
    47
    Market Cap (Dec-25-2022)
    195.460 Billion USD
    World Rank (Jan-07-2022)
    61
    Market Cap (Jan-07-2022)
    201.26 Billion USD
    Annual Revenue in USD
    46,660 Million USD
    Annual Operating Income in USD
    9,769 Million USD
    Annual Net Income in USD
    14,850 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Novartis is Switzerland based Multi-National Healthcare and Pharmaceutical company. Novartis Company focus on patented medicines, generic medicines and eye care – segments where they have the innovation power and global scale necessary to compete effectively. At the same time, Novartis is expanding their presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high- quality medicines and healthcare.

    Facts About Company

    Novartis annual revenue was 51.83 billion USD for year ending Dec-2022 and annual operating profit was 9.19 billion USD and annual net income was 6.95 billion USD for the same period.

    Novartis had over 101,703 employees worldwide as on 2022.

    Split of Novartis annual revenue 50,545 billion USD for year ending Dec-2022, Innovative Medicines business segment earned 41,296 million USD revenue and Sandoz business segment earned 9,249 million USD revenue.

  6. AstraZeneca

    World Rank (Jan-05-2024)
    48
    Market Cap (Jan-05-2024)
    213.330 Billion USD
    World Rank (Jul-30-2023)
    44
    Market Cap (Jul-30-2023)
    221.350 Billion USD
    World Rank (Dec-25-2022)
    40
    Market Cap (Dec-25-2022)
    210.670 Billion USD
    World Rank (Jan-07-2022)
    71
    Market Cap (Jan-07-2022)
    178.12 Billion USD
    Annual Revenue in USD
    45,811 Million USD
    Annual Net Income in USD
    5,955 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    Company Profile

    AstraZeneca is UK Based Pharmaceutical and Bio-Technology Company. They have done some advanced research on Oncology. In the fight against COVID-19, AstraZeneca is one among World Top 5 Companies which has done advanced phase of Covid-19 testing in collaboration with the University of Oxford. Headquarters is in UK.

    AstraZeneca Product Sales of 43,789 million USD split by Disease Area for year ending Dec-2023

    Facts About Company

    For year ending Dec-2023, AstraZeneca annual Total revenue was 45,811 million USD and annual operating profit was 8,193 million USD and annual net income was 5,961 million USD.

    AstraZeneca annual revenue was 44,351 million USD for year ending Dec-2022 and annual operating profit was 3,757 million USD and annual net income was 3,293 million USD for year ending Dec-2022.

    AstraZeneca has 89,900 employees as of 2023. 

  7. Pfizer

    World Rank (Jan-05-2024)
    67
    Market Cap (Jan-05-2024)
    167.868 Billion USD
    World Rank (Jul-30-2023)
    53
    Market Cap (Jul-30-2023)
    203.630 Billion USD
    World Rank (Dec-25-2022)
    28
    Market Cap (Dec-25-2022)
    290.940 Billion USD
    World Rank (Jan-07-2022)
    27
    Market Cap (Jan-07-2022)
    312.75 Billion USD
    Annual Revenue in USD
    58,496 Million USD
    Annual Operating Income in USD
    3,359 Million USD
    Annual Net Income in USD
    2,119 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Pfizer is one of World's Top Pharmaceutical company and its headquarters is in New York, USA. Pfizer Products and Medicines are the results of 1500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription. Pfizer develops medicines from simple diseases to most complex diseases in the world and their products are pharmaceutical drugs, vaccines.

    Facts About Company

    As of 2022, Pfizer has 83,000 employees.

    Pfizer annual revenue generated for period ending Dec-2022 was 100.33 billion USD.

    Pfizer annual net income generated for period ending Dec-2022 was 31.37 billion USD.

    As of 2021, Pfizer has 79,000 employees.

    Pfizer annual revenue generated for period ending Dec-2021 was 81.28 million USD.

    Pfizer annual net income generated for period ending Dec-2021 was 21.98 million USD.

  8. Bristol-Myers Squibb Company

    World Rank (Jan-05-2024)
    130
    Market Cap (Jan-05-2024)
    106.418 Billion USD
    World Rank (Jul-30-2023)
    100
    Market Cap (Jul-30-2023)
    129.010 Billion USD
    World Rank (Dec-25-2022)
    66
    Market Cap (Dec-25-2022)
    154.980 Billion USD
    World Rank (Jan-07-2022)
    96
    Market Cap (Jan-07-2022)
    139.46 Billion USD
    Annual Revenue in USD
    45,006 Million USD
    Annual Operating Income in USD
    8,195 Million USD
    Annual Net Income in USD
    8,025 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Bristol-Myers Squibb is USA based healthcare and pharmaceutical multi-national company.

    BMS is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

    Company has over 32,200 employees as on 2021. Headquarters is in USA.

    BMS discover, develop and deliver innovative medicines that help patients prevail over serious diseases

    BMS be the biopharma company that transforms patients' lives through science.

    Facts About Company

    As on 2022, Bristol-Myers Squibb has 34,300 employees.

    Bristol-Myers Squibb annual revenue generated for period ending Dec-2022 was 46,159 million USD.

    Bristol-Myers Squibb annual net income generated for period ending Dec-2022 was 6,327 million USD.

    As on 2021, BMS had strong financial results with total revenues growing 9 percent year-over-year to $46.4 billion.

    Bristol-Myers Squibb annual revenue generated for period ending Dec-2021 was 46,385 million USD.

  9. Regeneron Pharmaceuticals

    World Rank (Jan-05-2024)
    144
    Market Cap (Jan-05-2024)
    100.011 Billion USD
    World Rank (Jul-30-2023)
    174
    Market Cap (Jul-30-2023)
    81.855 Billion USD
    World Rank (Dec-25-2022)
    166
    Market Cap (Dec-25-2022)
    79.143 Billion USD
    World Rank (Jan-07-2022)
    279
    Market Cap (Jan-07-2022)
    64.93 Billion USD
    Annual Revenue in USD
    13,117 Million USD
    Annual Operating Income in USD
    4,233 Million USD
    Annual Net Income in USD
    3,953 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    REGENERON PHARMACEUTICALS is Bio-Pharmaceutical company with headquarters is in New York, USA.

    As on 2022, REGENERON PHARMACEUTICALS has 11,851 employees.

    Facts About Company

    REGENERON PHARMACEUTICALS annual revenue generated for period ending Dec-2022 was 12,172 million USD.

    REGENERON PHARMACEUTICALS annual net income generated for period ending Dec-2022 was 4,338 million USD.

    As on 2022, they had 11,851 employees. They had 7 FDA approved medicines.

  10. Zoetis

    World Rank (Jan-05-2024)
    168
    Market Cap (Jan-05-2024)
    89.086 Billion USD
    World Rank (Jul-30-2023)
    164
    Market Cap (Jul-30-2023)
    87.755 Billion USD
    World Rank (Dec-25-2022)
    202
    Market Cap (Dec-25-2022)
    67.935 Billion USD
    World Rank (Jan-07-2022)
    156
    Market Cap (Jan-07-2022)
    99.87 Billion USD
    Annual Revenue in USD
    8,544 Million USD
    Annual Operating Income in USD
    3,069 Million USD
    Annual Net Income in USD
    2,344 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Zoetis is a Pharmaceutical company manufacturing medicine and vaccinations for animals. Headquarters is in USA. As on 2021, Zoetis have over 12,100 employees. Zoetis headquarters is in USA.

    As on 2022, Zoetis has 13,800 employees.

    Zoetis annual revenue generated for period ending Dec-2022 was 8,080 million USD.

    Zoetis annual net income generated for period ending Dec-2022 was 2,114 million USD.

Share

Ads